128 related articles for article (PubMed ID: 23466166)
1. [Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Mar; 140(3):246-7. PubMed ID: 23466166
[No Abstract] [Full Text] [Related]
2. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous panniculitis-like T-cell lymphoma.
Tomasini D; Berti E
G Ital Dermatol Venereol; 2013 Aug; 148(4):395-411. PubMed ID: 23900161
[TBL] [Abstract][Full Text] [Related]
4. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
Tsukasaki K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
[No Abstract] [Full Text] [Related]
5. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
[No Abstract] [Full Text] [Related]
6. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
Cervigón I; Palomo A; Torres-Iglesias LM; Solano F; Zapata AM
Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
[No Abstract] [Full Text] [Related]
7. Subcutaneous panniculitis-like T-cell lymphoma after rituximab.
Sluzevich JC; Hall MR; Roy V
J Am Acad Dermatol; 2012 Nov; 67(5):e223-5. PubMed ID: 23062926
[No Abstract] [Full Text] [Related]
8. [Modern times: back to past, back to future].
Feliu J; Zabalza A; García-Muñoz R; Olavarría E
Med Clin (Barc); 2012 Jul; 139(4):180-1. PubMed ID: 22281094
[No Abstract] [Full Text] [Related]
9. [Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia].
Fang C; Xu W; Xu M; Hong M; Zhu DX; Zhu HY; Wu YJ; Fan L; Qiao C; Zhuang Y; Miao KR; Liu P; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):3-7. PubMed ID: 21429392
[TBL] [Abstract][Full Text] [Related]
10. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
Brown JR
Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
[No Abstract] [Full Text] [Related]
11. Exacerbation of lymphomatoid papulosis during rituximab therapy.
McCurdy O; McCormack C; Ritchie D; Prince HM
Australas J Dermatol; 2014 Feb; 55(1):e1-3. PubMed ID: 23190403
[TBL] [Abstract][Full Text] [Related]
12. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Ahmadi T; Schuster SJ
J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
[No Abstract] [Full Text] [Related]
13. An unusual ulcer in an 8-year-old girl.
Friedman A; Abadi M; Wu K; Fisher M; Abadi J
Dermatol Online J; 2010 Feb; 16(2):6. PubMed ID: 20178702
[No Abstract] [Full Text] [Related]
14. Paraneoplastic pemphigus despite treatment with rituximab, fludarabine and cyclophosphamide in chronic lymphocytic leukemia.
Schierl M; Foedinger D; Geissler K; Rappersberger K; Feldmann R
Eur J Dermatol; 2008; 18(6):717-8. PubMed ID: 19049939
[No Abstract] [Full Text] [Related]
15. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Marchand T; Revest M; Tattevin P; Chevrier S; Poullot E; Lamy T; Houot R
Leuk Lymphoma; 2013 Mar; 54(3):643-5. PubMed ID: 22924391
[No Abstract] [Full Text] [Related]
16. Acute myeloid leukemia with 11q23/MLL rearrangement after 'FCR' regimen for chronic lymphocytic leukemia.
Sarid N; Eshel R; Rothman R; Shpringer M; Perry C; Solar I; Dezorella N; Gepstein L; Canaani J; Naparstek E; Polliack A; Herishanu Y
Eur J Haematol; 2012 Nov; 89(5):430-1. PubMed ID: 22816611
[No Abstract] [Full Text] [Related]
17. Second malignancies in chronic lymphocytic leukemia.
Streu E
Oncol Nurs Forum; 2014 Jan; 41(1):95-8. PubMed ID: 24368244
[No Abstract] [Full Text] [Related]
18. Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature.
Uprety D; Peterson A; Shah BK
Ann Hematol; 2013 Jan; 92(2):271-3. PubMed ID: 22875063
[No Abstract] [Full Text] [Related]
19. Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
Robak T; Dmoszynska A; Solal-Céligny P; Warzocha K; Loscertales J; Catalano J; Afanasiev BV; Larratt L; Geisler CH; Montillo M; Zyuzgin I; Ganly PS; Dartigeas C; Rosta A; Maurer J; Mendila M; Saville MW; Valente N; Wenger MK; Moiseev SI
J Clin Oncol; 2010 Apr; 28(10):1756-65. PubMed ID: 20194844
[TBL] [Abstract][Full Text] [Related]
20. [T-cell panniculitis-like lymphoma of the subcutaneous fat: clinicomorphological and immunohistochemical analysis].
Leenman EE; Krivolapov IuA; Morozova EV
Arkh Patol; 2005; 67(2):43-6. PubMed ID: 15938121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
